Proactive Investors - Run By Investors For Investors
Market: AMEX
52-week High/Low: $4.77 / $2.02
Sector: Pharmaceuticals
Market Cap: $261.32M


BioTime, Inc. is a biotechnology company engaged in two areas of biomedical research and product development. The Company’s first business segment is blood plasma volume expanders and related technology for use in surgery, emergency trauma treatment, and other applications. Its lead blood plasma expander product, Hextend, is a physiologically balanced intravenous solution used in the treatment of hypovolemia. Its second business segment is regenerative medicine. Regenerative medicine refers to therapies based on human embryonic stem (hES) cell technology designed to rebuild cell and tissue function lost due to degenerative disease or injury.

Interactive graph

col 3
col 4
col 5
col 6

© Proactive Investors 2016

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.